Oral Minoxidil appears to work substantially better in patients with low SULT1A1 enzyme activity 9/20/2026
Oral Minoxidil works better for those with low SULT1A1 enzyme activity, while topical Minoxidil may be more effective for others. Some users report better results with topical Minoxidil, suggesting individual responses vary.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Reasons why Topical worked but Oral Minoxidil didn’t?
Some people find topical minoxidil effective for hair loss, but oral minoxidil doesn't work for them, possibly due to absorption issues. Others have had better results with oral minoxidil, suggesting individual responses vary.
community Any long term positive experiences with just minoxidil plus a dermaroller?
Minoxidil and dermarolling can yield positive hair growth results, but long-term effectiveness varies, and some users experience hair loss again without additional treatments like finasteride. Microneedling enhances minoxidil's effectiveness by increasing enzyme activity, but individual experiences differ.
community Will oral minoxidil accelerate twink death?
Oral minoxidil can increase body hair growth, but effects differ among individuals. Some recommend topical minoxidil to prevent unwanted body hair while preserving scalp hair.
community Can someone explain why it's "dumb" to just drink topical liquid minoxidil?
The conversation discusses the risks and methods of ingesting liquid minoxidil for hair loss. Concerns include dosing accuracy, safety of ingredients, and potential side effects compared to using oral minoxidil tablets.
community Roughly 1.5 years of treatment, don't give up!
The user shared their hair regrowth journey using finasteride, oral minoxidil, and dutasteride over 1.5 years, showing significant improvement. They experienced no side effects and noted increased body hair growth with oral minoxidil.
Related Research
6 / 6 resultsresearch Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants predicts response to oral minoxidil treatment for female pattern hair loss
This article discusses the role of Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants in predicting the response to oral minoxidil for treating female pattern hair loss, without presenting new research findings.
research SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth
In this study, the addition of a SULT1A1 enzyme booster to daily 5% minoxidil treatment significantly increased hair regrowth in men with androgenic alopecia compared to minoxidil alone.
research Minoxidil sulfotransferase enzymatical activity in plants: A novel paradigm in increasing minoxidil response in androgenetic alopecia
This study characterized the activity of naturally occurring minoxidil sulfotransferase enzymes in various plants and found that seven out of ten botanical extracts showed significant activity, suggesting these could potentially enhance minoxidil response in treating androgenetic alopecia.
research Hair follicle sulfotransferase activity and effectiveness of oral minoxidil in androgenetic alopecia
This study found that 63.4% of androgenetic alopecia patients showed clinical improvement after 6 months of low-dose oral minoxidil, with patients having low sulfotransferase activity in hair follicles responding more favorably than those with high enzyme activity.
research Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review
This review discusses the potential of using SULT1A1 expression in the scalp as a biomarker to predict response to minoxidil treatment for androgenetic alopecia, but reports no new clinical results.
research Comprehensive analysis of minoxidil effectiveness for hair growth
This study reviewed the evidence on minoxidil's effectiveness for androgenetic alopecia, finding that 5% topical minoxidil is the most effective monotherapy for men, while 2% is similarly effective for women. Genetic markers can predict response, and new formulations like foam and gel improve tolerability.